SHAREHOLDER ALERT: Weiss Law Reminds BTRS, RMED, CYBE, and LTRY Shareholders About Its Ongoing Investigations

NEW YORK, Oct. 3, 2022

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BTRS Holdings Inc. (NASDAQ: BTRS) in connection with the proposed acquisition of BTRS by EQT X fund. Under the terms of the merger agreement, the Company's shareholders will receive $9.50 in cash for each share of BTRS common stock owned. If you own BTRS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/btrs

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors Ra Medical Systems, Inc. (NYSE: RMED) in connection with the proposed merger of the Company with Catheter Precision, Inc. ("Catheter Precision"). The Merger is structured as a stock for stock reverse merger whereby all of Catheter Precision's outstanding convertible promissory notes and equity interests are to be exchanged for shares of RMED common stock and Catheter Precision options assumed by RMED. If you own RMED shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/rmed

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CyberOptics Corporation (NASDAQ: CYBE) in connection with the proposed acquisition of CYBE by Nordson Corporation. Pursuant to the merger agreement, CYBE shareholders will receive $54.00 in cash for each share of CYBE common stock owned. If you own CYBE shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/cybe